A multicentre cohort study to redefine and validate pathological assessment of response to neoadjuvant therapy in treated oesophagogastric adenocarcinoma.

Richard Turkington, Megan Lloyd, Fergus Noble, Rob Walker, Damian McManus, Matt Bedford, Ewen Griffiths, John Whiting, Barbara Nutzinger, Nicola Grehan, Robert O'Neill, Richard Skipworth, Vicki Save, Sutaria Rupesh, Stuart Mercer, John Saunders, Irshad Soomro, Simon Parsons, Rebecca C. Fitzgerald, Timothy Underwood

Research output: Contribution to conferenceAbstract

Original languageEnglish
Publication statusPublished - 06 Nov 2016
EventNCRI Cancer Conference 2016 - Liverpool, United Kingdom
Duration: 06 Nov 201609 Nov 2016

Conference

ConferenceNCRI Cancer Conference 2016
CountryUnited Kingdom
CityLiverpool
Period06/11/201609/11/2016

Keywords

  • oesophageal cancer

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Turkington, R., Lloyd, M., Noble, F., Walker, R., McManus, D., Bedford, M., Griffiths, E., Whiting, J., Nutzinger, B., Grehan, N., O'Neill, R., Skipworth, R., Save, V., Rupesh, S., Mercer, S., Saunders, J., Soomro, I., Parsons, S., Fitzgerald, R. C., & Underwood, T. (2016). A multicentre cohort study to redefine and validate pathological assessment of response to neoadjuvant therapy in treated oesophagogastric adenocarcinoma.. Abstract from NCRI Cancer Conference 2016, Liverpool, United Kingdom. http://abstracts.ncri.org.uk/abstract/a-multicentre-cohort-study-to-redefine-and-validate-pathological-assessment-of-response-to-neoadjuvant-therapy-in-treated-oesophagogastric-adenocarcinoma/